The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07)
暂无分享,去创建一个
L. Boersma | S. Linn | K. K. van de Vijver | V. Tjan-Heijnen | J. A. van der Hage | L. Strobbe | V. Tjan-Heijnen | A. Kessels | J. D. de Wilt | T. van Dalen | M. Lobbes | M. Smidt | A. H. Westenberg | L. V. van Roozendaal | T. Dalen | J. de Vries | A. Kessels | L. Strobbe | P. Poortmans | L. Roozendaal | K. V. D. Vijver | Liesbeth J. Boersma | S. C. Linn | J. A. V. D. Hage | J. D. Vries | Philip Poortmans | J. D. Wilt
[1] L. Strobbe,et al. Meta‐analysis of ultrasound‐guided biopsy of suspicious axillary lymph nodes in the selection of patients with extensive axillary tumour burden in breast cancer , 2015, The British journal of surgery.
[2] Mechthild Krause,et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] E. Rutgers,et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] V. Tjan-Heijnen,et al. Inconsistent selection and definition of local and regional endpoints in breast cancer research , 2014, The British journal of surgery.
[5] M. Piccart,et al. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. , 2014, Journal of the National Cancer Institute.
[6] R. Mansel,et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.
[7] R. Beets-Tan,et al. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? , 2013, Breast.
[8] S. Goyal,et al. Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents. , 2013, Breast.
[9] R. Bosc,et al. The standard tangential fields used for breast irradiation do not allow optimal coverage and dose distribution in axillary levels I-II and the sentinel node area. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[10] B. Newman,et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.
[11] A. Luini,et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.
[12] S. Rodenhuis,et al. Early Assessment of Axillary Response with 18F-FDG PET/CT during Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla , 2013, Annals of Surgical Oncology.
[13] W. Mali,et al. Value of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Preventing Completion Axillary Lymph Node Dissection in Breast Cancer: A Systematic Review and Meta-Analysis , 2013, Annals of Surgical Oncology.
[14] M. Silverstein,et al. Accuracy of Predicting Axillary Lymph Node Positivity by Physical Examination, Mammography, Ultrasonography, and Magnetic Resonance Imaging , 2012, Annals of Surgical Oncology.
[15] S. Ciatto,et al. Preoperative Ultrasound-Guided Needle Biopsy of Axillary Nodes in Invasive Breast Cancer: Meta-Analysis of Its Accuracy and Utility in Staging the Axilla , 2011, Annals of surgery.
[16] M. Christiaens,et al. Lymphoedema Functioning, Disability and Health Questionnaire (Lymph-ICF): Reliability and Validity , 2011, Physical Therapy.
[17] L. Strobbe,et al. Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy , 2011, The British journal of surgery.
[18] A. Giuliano,et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.
[19] P. Iyengar,et al. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer , 2011 .
[20] T. Julian,et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. , 2010, The Lancet. Oncology.
[21] Kelly K. Hunt,et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. , 2010, Annals of surgery.
[22] Hiroyuki Abe,et al. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients. , 2009, Radiology.
[23] B. Cady,et al. Axillary lymph nodes: US-guided fine-needle aspiration for initial staging of breast cancer--correlation with primary tumor size. , 2008, Radiology.
[24] J. Vries,et al. Personality Predicts Quality of Life Six Months after the Diagnosis and Treatment of Breast Disease , 2007, Annals of Surgical Oncology.
[25] M. Hočevar,et al. Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients , 2006, Breast Cancer Research and Treatment.
[26] E. Steegers,et al. Validation of the Dutch Short Form of the State Scale of the Spielberger State-Trait Anxiety Inventory: Considerations for Usage in Screening Outcomes , 2003, Public Health Genomics.
[27] F. Peintinger,et al. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients , 2003, British Journal of Cancer.
[28] Jong-Hyeon Jeong,et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. , 2002, The New England journal of medicine.
[29] A. Vincent-Salomon,et al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[31] N. Aaronson,et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[33] M. Pamilo,et al. Real‐time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.